{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:12:25Z","timestamp":1783703545786,"version":"3.55.0"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["206248\/Z\/17\/Z"],"award-info":[{"award-number":["206248\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer&apos;s Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell &amp; Developmental Biology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.semcdb.2021.09.012","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T02:21:22Z","timestamp":1634178082000},"page":"138-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Targeted protein degradation using intracellular antibodies and its application to neurodegenerative disease"],"prefix":"10.1016","volume":"126","author":[{"given":"Jonathan A.","family":"Benn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir S.","family":"Mukadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"McEwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2021.09.012_bib1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/bmj.n156","article-title":"Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis","volume":"372","author":"Ackley","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.semcdb.2021.09.012_bib2","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1038\/s41598-019-41105-4","article-title":"Antibody-mediated clearance of tau in primary mouse microglial cultures requires Fc\u03b3-receptor binding and functional lysosomes","volume":"9","author":"Andersson","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcdb.2021.09.012_bib3","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","article-title":"Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements","volume":"27","author":"Asuni","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.semcdb.2021.09.012_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ymeth.2004.04.004","article-title":"Antigen-independent selection of intracellular stable antibody frameworks","volume":"34","author":"Auf der Maur","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.semcdb.2021.09.012_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-021-01147-0","article-title":"Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice","volume":"9","author":"Bajracharya","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.semcdb.2021.09.012_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutatons: a follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.semcdb.2021.09.012_bib7","doi-asserted-by":"crossref","first-page":"29199","DOI":"10.1371\/journal.pone.0029199","article-title":"Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments","volume":"6","author":"Butler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2021.09.012_bib8","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.4049\/jimmunol.152.7.3675","article-title":"Autoantibody responses to the \u201cnative\u201d 52-kDa SS-A\/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren\u2019s syndrome","volume":"152","author":"Buyon","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib9","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106228","article-title":"Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity","volume":"40","author":"Caddy","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.semcdb.2021.09.012_bib10","first-page":"2638","article-title":"A new means of inducibly inactivating a cellular protein","volume":"8","author":"Carlson","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nsmb.2180","article-title":"Fluorescent fusion protein knockout mediated by anti-GFP nanobody","volume":"19","author":"Caussinus","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib12","doi-asserted-by":"crossref","first-page":"34457","DOI":"10.1074\/jbc.M111.229633","article-title":"Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression","volume":"286","author":"Chai","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2021.09.012_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.semcdb.2021.09.012_bib14","first-page":"1","article-title":"Proteasome-targeted nanobodies alleviate pathology and functional decline in an \u03b1-synuclein-based Parkinson\u2019s disease model","volume":"4","author":"Chatterjee","year":"2018","journal-title":"npj Park. Dis."},{"key":"10.1016\/j.semcdb.2021.09.012_bib15","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","article-title":"Gene therapy for neurodegenerative disorders: advances, insights and prospects","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.semcdb.2021.09.012_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13059-019-1624-4","article-title":"Degradation of endogenous proteins and generation of a null-like phenotype in zebrafish using Trim-Away technology","volume":"20","author":"Chen","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/genes12060948","article-title":"Administration of AAV-alpha synuclein NAC antibody improves locomotor behavior in rats overexpressing alpha synuclein","volume":"12","author":"Chen","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.semcdb.2021.09.012_bib18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4161\/mabs.36389","article-title":"A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells","volume":"6","author":"Choi","year":"2014","journal-title":"mAbs"},{"key":"10.1016\/j.semcdb.2021.09.012_bib19","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.cell.2017.10.033","article-title":"A method for the acute and rapid degradation of endogenous proteins","volume":"171","author":"Clift","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2021.09.012_bib20","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1038\/s41596-018-0028-3","article-title":"Acute and rapid degradation of endogenous proteins by Trim-Away","volume":"13","author":"Clift","year":"2018","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.semcdb.2021.09.012_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135633","article-title":"\u03b1-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease","volume":"6","author":"Cole","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.semcdb.2021.09.012_bib22","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awu213","article-title":"Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer\u2019s disease","volume":"137","author":"Collin","year":"2014","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib23","doi-asserted-by":"crossref","first-page":"35452","DOI":"10.1074\/jbc.M113.491001","article-title":"Antibody uptake into neurons occurs primarily via clathrin-dependent Fc\u03b3 receptor endocytosis and is a prerequisite for acute tau protein clearance","volume":"288","author":"Congdon","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2021.09.012_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib25","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.semcdb.2021.09.012_bib26","doi-asserted-by":"crossref","unstructured":"C. Danis, E. Dupr\u00e9, O.\u00a0Zejneli, R. Caillierez, A.\u00a0Arrial, S. B\u00e9gard\u00a0, A. Loyens\u00a0, J. Mortelecque,\u00a0, F.-X. Cantrelle, X. Hanoulle\u00a0, J.-C. Rain\u00a0, M.\u00a0Colin, L. Bu\u00e9e , I. Landrieu Inhibition of Tau seeding by targeting tau nucleation core within neurons with a single domain antibody fragment, 2021, bioRxiv 2021.03.23.436266. doi: 10.1101\/2021.03.23.436266.","DOI":"10.1101\/2021.03.23.436266"},{"key":"10.1016\/j.semcdb.2021.09.012_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tibtech.2014.03.001","article-title":"Nanobody-based products as research and diagnostic tools","volume":"32","author":"De Meyer","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2019.11.014","article-title":"Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours","volume":"317","author":"Debie","year":"2020","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.semcdb.2021.09.012_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.semcdb.2021.09.012_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32660","article-title":"Intracellular antibody signalling is regulated by phosphorylation of the Fc receptor TRIM21","volume":"7","author":"Dickson","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.semcdb.2021.09.012_bib31","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/acscentsci.0c01379","article-title":"Cell-permeant bioadaptors for cytosolic delivery of native antibodies: a \u201cMix-and-Go\u201d approach","volume":"6","author":"Du","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.semcdb.2021.09.012_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.semcdb.2021.09.012_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101523","article-title":"X-linked Huwe1 is essential for oocyte maturation and preimplantation embryo development","volume":"23","author":"Eisa","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.semcdb.2021.09.012_bib34","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ymthe.2018.06.021","article-title":"AAV5-miHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a Huntington\u2019s disease minipig model","volume":"26","author":"Evers","year":"2018","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.semcdb.2021.09.012_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ymeth.2004.04.007","article-title":"Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering","volume":"34","author":"Ewert","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.semcdb.2021.09.012_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2016.01.004","article-title":"Swine TRIM21 restricts FMDV infection via an intracellular neutralization mechanism","volume":"127","author":"Fan","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.semcdb.2021.09.012_bib37","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1073\/pnas.1507534112","article-title":"Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21","volume":"112","author":"Fletcher","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib38","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2019.0356","article-title":"Prion-like spreading of Alzheimer's disease within the brain's connectome","volume":"16","author":"Fornari","year":"2019","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.semcdb.2021.09.012_bib39","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.160255","article-title":"An affinity-directed protein missile system for targeted proteolysis","volume":"6","author":"Fulcher","year":"2016","journal-title":"Open Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-019-0340-6","article-title":"Targeting tauopathy with engineered tau-degrading intrabodies","volume":"14","author":"Gallardo","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.semcdb.2021.09.012_bib41","doi-asserted-by":"crossref","first-page":"18688","DOI":"10.1038\/s41598-019-55091-0","article-title":"Intracellular delivery of therapeutic antibodies into specific cells using antibody-peptide fusions","volume":"9","author":"Gaston","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcdb.2021.09.012_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2759-x","article-title":"Initiation of a conserved trophectoderm program in human, cow and mouse embryos","volume":"587","author":"Gerri","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2021.09.012_bib43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13024-020-00404-5","article-title":"Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer\u2019s disease","volume":"15","author":"Gibbons","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.semcdb.2021.09.012_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","article-title":"The propagation of prion-like protein inclusions in neurodegenerative diseases","volume":"33","author":"Goedert","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.semcdb.2021.09.012_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","article-title":"Propagation of tau aggregates and neurodegeneration","volume":"40","author":"Goedert","year":"2017","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.semcdb.2021.09.012_bib46","first-page":"586","article-title":"[Toxicity reduction of human islet amyloid polypeptide by Trim-Away technique in insulinoma cells]","volume":"42","author":"Gong","year":"2020","journal-title":"Yi Chuan Hered."},{"key":"10.1016\/j.semcdb.2021.09.012_bib47","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ymthe.2020.10.007","article-title":"Anti-tau scFvs targeted to the cytoplasm or secretory pathway variably modify pathology and neurodegenerative phenotypes","volume":"29","author":"Goodwin","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.semcdb.2021.09.012_bib48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-virology-092818-015550","article-title":"Adenovirus entry: from infection to immunity","volume":"6","author":"Greber","year":"2019","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib49","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/374168a0","article-title":"A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks","volume":"374","author":"Greenberg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2021.09.012_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123446","article-title":"Anti-Yo antibody uptake and interaction with its intracellular target antigen causes purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers","volume":"10","author":"Greenlee","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2021.09.012_bib51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12974-014-0160-0","article-title":"Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures","volume":"11","author":"Greenlee","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.semcdb.2021.09.012_bib52","doi-asserted-by":"crossref","first-page":"33081","DOI":"10.1074\/jbc.M113.494922","article-title":"Two novel tau antibodies targeting the 396\/404 region are primarily taken up by neurons and reduce tau protein pathology","volume":"288","author":"Gu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2021.09.012_bib53","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2021.09.012_bib54","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1158\/0008-5472.CAN-06-3783","article-title":"Antibody-mediated p53 protein therapy prevents liver metastasis in vivo","volume":"67","author":"Hansen","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcdb.2021.09.012_bib55","doi-asserted-by":"crossref","first-page":"20790","DOI":"10.1074\/jbc.C700090200","article-title":"Intranuclear protein transduction through a nucleoside salvage pathway","volume":"282","author":"Hansen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2021.09.012_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127474","article-title":"An effective cell-penetrating antibody delivery platform","volume":"4","author":"Herrmann","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.semcdb.2021.09.012_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1742-2094-6-31","article-title":"Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics","volume":"6","author":"Hill","year":"2009","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.semcdb.2021.09.012_bib58","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The neurotropic properties of AAV-PHP.B are limited to C57BL\/6J mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.semcdb.2021.09.012_bib59","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.molcel.2020.04.032","article-title":"Antibody RING-mediated destruction of endogenous proteins","volume":"79","author":"Ibrahim","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcdb.2021.09.012_bib60","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1073\/pnas.0609174104","article-title":"Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function","volume":"104","author":"James","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib61","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4161\/mabs.21696","article-title":"Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies","volume":"4","author":"Joshi","year":"2012","journal-title":"mAbs"},{"key":"10.1016\/j.semcdb.2021.09.012_bib62","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3389\/fimmu.2019.01139","article-title":"The role of antibodies and their receptors in protection against ordered protein assembly in neurodegeneration","volume":"10","author":"Katsinelos","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib63","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1073\/pnas.0800159105","article-title":"TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved","volume":"105","author":"Keeble","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","article-title":"The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics","volume":"140","author":"Kent","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib65","first-page":"27","article-title":"Phase I Study of 68Ga-HER2-nanobody for PET\/CT assessment of HER2 expression in breast carcinoma","volume":"57","author":"Keyaerts","year":"2016","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.semcdb.2021.09.012_bib66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2016.05.066","article-title":"Endosomal acidic pH-induced conformational changes of a cytosol-penetrating antibody mediate endosomal escape","volume":"235","author":"Kim","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.semcdb.2021.09.012_bib67","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/s41564-019-0592-5","article-title":"Cyclophilin A protects HIV-1 from restriction by human TRIM5\u03b1","volume":"4","author":"Kim","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib68","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1074\/jbc.M600937200","article-title":"Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity*","volume":"281","author":"Kim","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2021.09.012_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/157895","article-title":"Neutralization of virus infectivity by antibodies: old problems in new perspectives","volume":"2014","author":"Klasse","year":"2014","journal-title":"Adv. Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib70","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1006\/jmbi.1998.2238","article-title":"The fibronectin type III domain as a scaffold for novel binding proteins","volume":"284","author":"Koide","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib71","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature14658","article-title":"Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy","volume":"523","author":"Kondo","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2021.09.012_bib72","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1038\/s41598-018-26338-z","article-title":"The structural basis of nanobody unfolding reversibility and thermoresistance","volume":"8","author":"Kunz","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcdb.2021.09.012_bib73","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/978-1-4939-7825-0_23","article-title":"Translating antisense technology into a treatment for Huntington\u2019s disease","volume":"1780","author":"Lane","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib74","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.celrep.2016.06.099","article-title":"Antibody-mediated targeting of tau in vivo does not require effector function and microglial engagement","volume":"16","author":"Lee","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcdb.2021.09.012_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-170235","article-title":"Is Huntingtin dispensable in the adult brain?","volume":"6","author":"Liu","year":"2017","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.semcdb.2021.09.012_bib76","first-page":"12112","article-title":"Donanemab (LY3002813) dose-escalation study in Alzheimer\u2019s disease","volume":"7","author":"Lowe","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.semcdb.2021.09.012_bib77","doi-asserted-by":"crossref","first-page":"11161","DOI":"10.1038\/srep11161","article-title":"Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody","volume":"5","author":"Luo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcdb.2021.09.012_bib78","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jmb.2007.11.096","article-title":"An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity","volume":"377","author":"Lynch","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib79","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/gbe\/evt163","article-title":"An evolutionary screen highlights canonical and noncanonical candidate antiviral genes within the primate TRIM gene family","volume":"5","author":"Malfavon-Borja","year":"2013","journal-title":"Genome Biol. Evol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib80","doi-asserted-by":"crossref","first-page":"19985","DOI":"10.1073\/pnas.1014074107","article-title":"Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)","volume":"107","author":"Mallery","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib81","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neulet.2017.11.049","article-title":"Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain","volume":"665","author":"Matsuzaki","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.semcdb.2021.09.012_bib82","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1073\/pnas.1607215114","article-title":"Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation","volume":"114","author":"McEwan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib83","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1128\/JVI.00728-12","article-title":"Regulation of virus neutralization and the persistent fraction by TRIM21","volume":"86","author":"McEwan","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib84","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ni.2548","article-title":"Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21","volume":"14","author":"McEwan","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib85","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/biolre\/ioz106","article-title":"SNAP23 is required for constitutive and regulated exocytosis in mouse oocytes\u2020","volume":"101","author":"Mehlmann","year":"2019","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.semcdb.2021.09.012_bib86","doi-asserted-by":"crossref","first-page":"E2142","DOI":"10.1073\/pnas.1513943113","article-title":"Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus","volume":"113","author":"Monteith","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib87","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16228","article-title":"NaLi-H1: a universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies","volume":"5","author":"Moutel","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.semcdb.2021.09.012_bib88","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-6750-9-14","article-title":"A multi-Fc-species system for recombinant antibody production","volume":"9","author":"Moutel","year":"2009","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib89","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/brain\/awx052","article-title":"Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model","volume":"140","author":"Nisbet","year":"2017","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib90","doi-asserted-by":"crossref","first-page":"13324","DOI":"10.1073\/pnas.0404640101","article-title":"A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1","volume":"101","author":"Nisole","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib91","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington\u2019s disease patients","volume":"CB 19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib92","first-page":"748","article-title":"Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition","volume":"140","author":"Pontecorvo","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.semcdb.2021.09.012_bib93","first-page":"131","article-title":"Antibody- and TRIM21-dependent intracellular restriction of Salmonella enterica","volume":"72","author":"Rakebrandt","year":"2014","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.semcdb.2021.09.012_bib94","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0968-0004(96)10031-1","article-title":"PEST sequences and regulation by proteolysis","volume":"21","author":"Rechsteiner","year":"1996","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.semcdb.2021.09.012_bib95","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2567.2002.01417.x","article-title":"The 52 000 MW Ro\/SS-A autoantigen in Sj\u00f6gren\u2019s syndrome\/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures","volume":"106","author":"Rhodes","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.semcdb.2021.09.012_bib96","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature02777","article-title":"Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1","volume":"430","author":"Sayah","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2021.09.012_bib97","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1016\/j.celrep.2020.02.100","article-title":"Cyclophilin A prevents HIV-1 restriction in lymphocytes by blocking human TRIM5\u03b1 binding to the viral core","volume":"30","author":"Selyutina","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcdb.2021.09.012_bib98","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2021.09.012_bib99","doi-asserted-by":"crossref","first-page":"15090","DOI":"10.1038\/ncomms15090","article-title":"Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration","volume":"8","author":"Shin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcdb.2021.09.012_bib100","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1126\/sciadv.aay2174","article-title":"Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant-driven tumor growth","volume":"6","author":"Shin","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.semcdb.2021.09.012_bib101","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.semcdb.2021.09.012_bib102","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington\u2019s disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.semcdb.2021.09.012_bib103","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nature02343","article-title":"The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys","volume":"427","author":"Stremlau","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2021.09.012_bib104","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.drudis.2008.04.013","article-title":"DARPins: a new generation of protein therapeutics","volume":"13","author":"Stumpp","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.semcdb.2021.09.012_bib105","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/emboj\/cdg106","article-title":"Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation","volume":"22","author":"Tanaka","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.semcdb.2021.09.012_bib106","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1074\/jbc.M110.188193","article-title":"Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain*","volume":"286","author":"Tanaka","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2021.09.012_bib107","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/372363a0","article-title":"Functional association of cyclophilin A with HIV-1 virions","volume":"372","author":"Thali","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2021.09.012_bib108","unstructured":"Up-and-Coming Immunotherapies Target A\u03b2 and Tau | ALZFORUM [WWW Document], n.d. \u3008https:\/\/www.alzforum.org\/news\/conference-coverage\/and-coming-immunotherapies-target-av-and-tau\u3009 (Accessed 9 January 2021)."},{"key":"10.1016\/j.semcdb.2021.09.012_bib109","doi-asserted-by":"crossref","first-page":"12397","DOI":"10.1073\/pnas.1301918110","article-title":"Intracellular antibody receptor TRIM21 prevents fatal viral infection","volume":"110","author":"Vaysburd","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib110","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/bit.26567","article-title":"Antibody glycoengineering strategies in mammalian cells","volume":"115","author":"Wang","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.semcdb.2021.09.012_bib111","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12987-018-0093-6","article-title":"Monoclonal antibody exposure in rat and cynomolgus monkey cerebrospinal fluid following systemic administration","volume":"15","author":"Wang","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.semcdb.2021.09.012_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005253","article-title":"TRIM21 promotes cGAS and RIG-I sensing of viral genomes during infection by antibody-opsonized virus","volume":"11","author":"Watkinson","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.semcdb.2021.09.012_bib113","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe1611","article-title":"Persistent repression of tau in the brain using engineered zinc finger protein transcription factors","volume":"7","author":"Wegmann","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.semcdb.2021.09.012_bib114","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ydbio.2020.10.014","article-title":"Trim-Away mediated knock down uncovers a new function for Lbh during gastrulation of Xenopus laevis","volume":"470","author":"Weir","year":"2021","journal-title":"Dev. Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0304-3835(03)00151-4","article-title":"Nuclear delivery of p53C-terminal peptides into cancer cells using scFv fragments of a monoclonal antibody that penetrates living cells","volume":"195","author":"Weisbart","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcdb.2021.09.012_bib116","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1073\/pnas.0802759105","article-title":"Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease","volume":"105","author":"White","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib117","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1073\/pnas.0709003105","article-title":"Independent evolution of an antiviral TRIMCyp in rhesus macaques","volume":"105","author":"Wilson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib118","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1365-3083.1999.00547.x","article-title":"Protein\u2013protein interactions between native Ro52 and immunoglobulin G heavy chain","volume":"49","author":"Yang","year":"1999","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib119","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0161-5890(00)00068-7","article-title":"Autoantigen Ro52 directly interacts with human IgG heavy chain in vivo in mammalian cells","volume":"37","author":"Yang","year":"2000","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib120","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.4049\/jimmunol.157.5.2082","article-title":"Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody","volume":"157","author":"Zack","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib121","series-title":"Immunotherapy Targeting Amyloid-\u03b2 peptides in Alzheimer\u2019s Disease","first-page":"23","author":"Zampar","year":"2020"},{"key":"10.1016\/j.semcdb.2021.09.012_bib122","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41594-021-00560-2","article-title":"Target-induced clustering activates Trim-Away of pathogens and proteins","volume":"28","author":"Zeng","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.semcdb.2021.09.012_bib123","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7150\/thno.20047","article-title":"A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.semcdb.2021.09.012_bib124","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/emboj\/cdg158","article-title":"Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.semcdb.2021.09.012_bib125","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1080\/15384101.2019.1661173","article-title":"Loss of CENPF leads to developmental failure in mouse embryos","volume":"18","author":"Zhou","year":"2019","journal-title":"Cell Cycle Georget. Tex."},{"key":"10.1016\/j.semcdb.2021.09.012_bib126","first-page":"385","article-title":"EB1 is essential for spindle formation and chromosome alignment during oocyte meiotic maturation in Mice","volume":"27","author":"Zhou","year":"2021","journal-title":"Microsc. Microanal. J. Microsc. Soc. Am. Microbe Anal. Soc. Microsc. Soc. Can."},{"key":"10.1016\/j.semcdb.2021.09.012_bib127","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/bi0491604","article-title":"The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence","volume":"44","author":"Ziegler","year":"2005","journal-title":"Biochemistry"},{"issue":"44","key":"10.1016\/j.semcdb.2021.09.012_bib128","doi-asserted-by":"crossref","first-page":"22132","DOI":"10.1073\/pnas.1913973116","article-title":"Cytosolic delivery of inhibitory antibodies with cationic lipids","volume":"116","author":"Wang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcdb.2021.09.012_bib129","article-title":"Virus neutralisation by intracellular antibodies","author":"Botterman","year":"2021","journal-title":"Seminars In Cell and Developmental Biology"},{"key":"10.1016\/j.semcdb.2021.09.012_bib130","unstructured":"Leo Kiss, Leo James, The mechanism of the intracellular antibody-receptor and RING E3 ligase TRIM21, Seminars In Cell\u00a0and Developmental Biology, In this issue."},{"issue":"4","key":"10.1016\/j.semcdb.2021.09.012_bib131","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neuron.2019.11.007","article-title":"Antibody Therapy Targeting RAN Proteins Rescues C9 ALS\/FTD Phenotypes in C9orf72 Mouse Model","volume":"105","author":"Nguyen","year":"2020","journal-title":"Neuron"}],"container-title":["Seminars in Cell &amp; Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952121002470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952121002470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:11:34Z","timestamp":1761066694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952121002470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":131,"alternative-id":["S1084952121002470"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2021.09.012","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted protein degradation using intracellular antibodies and its application to neurodegenerative disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2021.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}